nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—SLC22A2—Vinblastine—germ cell cancer	0.213	0.397	CbGbCtD
Disopyramide—SLC22A2—Cisplatin—germ cell cancer	0.195	0.364	CbGbCtD
Disopyramide—CYP3A4—Ifosfamide—germ cell cancer	0.064	0.119	CbGbCtD
Disopyramide—CYP3A4—Vinblastine—germ cell cancer	0.0339	0.0633	CbGbCtD
Disopyramide—CYP3A4—Etoposide—germ cell cancer	0.0306	0.057	CbGbCtD
Disopyramide—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.013	0.0972	CbGpPWpGaD
Disopyramide—Cardiogenic shock—Ifosfamide—germ cell cancer	0.0122	0.0538	CcSEcCtD
Disopyramide—SLC22A1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.0122	0.0906	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.00924	0.0688	CbGpPWpGaD
Disopyramide—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.00895	0.0667	CbGpPWpGaD
Disopyramide—SLC22A1—Organic cation transport—SLC22A3—germ cell cancer	0.00835	0.0622	CbGpPWpGaD
Disopyramide—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00749	0.0558	CbGpPWpGaD
Disopyramide—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00698	0.052	CbGpPWpGaD
Disopyramide—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00607	0.0452	CbGpPWpGaD
Disopyramide—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00566	0.0422	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.00506	0.0377	CbGpPWpGaD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.00485	0.0361	CbGpPWpGaD
Disopyramide—SLC22A1—ganglion—germ cell cancer	0.0047	0.046	CbGeAlD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.00467	0.0348	CbGpPWpGaD
Disopyramide—KCND2—brainstem—germ cell cancer	0.00467	0.0457	CbGeAlD
Disopyramide—Numbness—Vinblastine—germ cell cancer	0.00428	0.0188	CcSEcCtD
Disopyramide—KCND2—telencephalon—germ cell cancer	0.00414	0.0406	CbGeAlD
Disopyramide—Sensory loss—Vinblastine—germ cell cancer	0.0041	0.018	CcSEcCtD
Disopyramide—KCND3—brainstem—germ cell cancer	0.00407	0.0399	CbGeAlD
Disopyramide—KCND2—decidua—germ cell cancer	0.00392	0.0385	CbGeAlD
Disopyramide—KCND3—telencephalon—germ cell cancer	0.00361	0.0354	CbGeAlD
Disopyramide—KCND2—pituitary gland—germ cell cancer	0.00337	0.033	CbGeAlD
Disopyramide—Ventricular fibrillation—Ifosfamide—germ cell cancer	0.00335	0.0147	CcSEcCtD
Disopyramide—SLC22A2—trigeminal ganglion—germ cell cancer	0.00327	0.032	CbGeAlD
Disopyramide—KCND2—medulla oblongata—germ cell cancer	0.00325	0.0319	CbGeAlD
Disopyramide—CYP3A4—urine—germ cell cancer	0.00314	0.0308	CbGeAlD
Disopyramide—KCND3—uterus—germ cell cancer	0.00299	0.0293	CbGeAlD
Disopyramide—KCND2—midbrain—germ cell cancer	0.00297	0.0291	CbGeAlD
Disopyramide—KCND2—spinal cord—germ cell cancer	0.0029	0.0284	CbGeAlD
Disopyramide—Cyanosis—Etoposide—germ cell cancer	0.00286	0.0126	CcSEcCtD
Disopyramide—KCND2—female gonad—germ cell cancer	0.00281	0.0275	CbGeAlD
Disopyramide—KCND3—adrenal gland—germ cell cancer	0.00263	0.0257	CbGeAlD
Disopyramide—KCND3—midbrain—germ cell cancer	0.00259	0.0254	CbGeAlD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.00259	0.0193	CbGpPWpGaD
Disopyramide—KCND2—head—germ cell cancer	0.00258	0.0253	CbGeAlD
Disopyramide—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.00256	0.0113	CcSEcCtD
Disopyramide—Tingling sensation—Etoposide—germ cell cancer	0.00252	0.0111	CcSEcCtD
Disopyramide—KCND2—testis—germ cell cancer	0.00249	0.0244	CbGeAlD
Disopyramide—Numbness—Etoposide—germ cell cancer	0.00244	0.0107	CcSEcCtD
Disopyramide—Apnoea—Etoposide—germ cell cancer	0.00239	0.0105	CcSEcCtD
Disopyramide—Coma—Ifosfamide—germ cell cancer	0.00234	0.0103	CcSEcCtD
Disopyramide—Sensory loss—Etoposide—germ cell cancer	0.00234	0.0103	CcSEcCtD
Disopyramide—KCND2—cerebellum—germ cell cancer	0.0023	0.0225	CbGeAlD
Disopyramide—KCND3—head—germ cell cancer	0.00225	0.022	CbGeAlD
Disopyramide—KCND3—testis—germ cell cancer	0.00217	0.0213	CbGeAlD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00205	0.0152	CbGpPWpGaD
Disopyramide—KCND3—cerebellum—germ cell cancer	0.00201	0.0197	CbGeAlD
Disopyramide—Depression—Vinblastine—germ cell cancer	0.00198	0.00871	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00197	0.0147	CbGpPWpGaD
Disopyramide—Cardiac failure—Ifosfamide—germ cell cancer	0.00191	0.00838	CcSEcCtD
Disopyramide—KCND2—brain—germ cell cancer	0.00187	0.0183	CbGeAlD
Disopyramide—Agranulocytosis—Vinblastine—germ cell cancer	0.00185	0.00815	CcSEcCtD
Disopyramide—CHRM2—telencephalon—germ cell cancer	0.00184	0.0181	CbGeAlD
Disopyramide—Psychotic disorder—Ifosfamide—germ cell cancer	0.00182	0.00799	CcSEcCtD
Disopyramide—SLC22A1—telencephalon—germ cell cancer	0.00181	0.0178	CbGeAlD
Disopyramide—Hypoaesthesia—Vinblastine—germ cell cancer	0.00177	0.0078	CcSEcCtD
Disopyramide—Cardiac arrest—Ifosfamide—germ cell cancer	0.00177	0.00778	CcSEcCtD
Disopyramide—Urinary retention—Ifosfamide—germ cell cancer	0.00177	0.00778	CcSEcCtD
Disopyramide—Cardiac failure congestive—Cisplatin—germ cell cancer	0.00177	0.00778	CcSEcCtD
Disopyramide—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00174	0.00766	CcSEcCtD
Disopyramide—Cyanosis—Methotrexate—germ cell cancer	0.00171	0.00753	CcSEcCtD
Disopyramide—Hypokalaemia—Ifosfamide—germ cell cancer	0.00169	0.00744	CcSEcCtD
Disopyramide—CHRM1—telencephalon—germ cell cancer	0.00168	0.0165	CbGeAlD
Disopyramide—Neutropenia—Dactinomycin—germ cell cancer	0.00164	0.00721	CcSEcCtD
Disopyramide—KCND3—brain—germ cell cancer	0.00163	0.016	CbGeAlD
Disopyramide—Cardiac failure congestive—Etoposide—germ cell cancer	0.00162	0.00712	CcSEcCtD
Disopyramide—KCND3—lymph node—germ cell cancer	0.00157	0.0154	CbGeAlD
Disopyramide—Cardiac failure—Etoposide—germ cell cancer	0.00151	0.00662	CcSEcCtD
Disopyramide—Dysuria—Ifosfamide—germ cell cancer	0.0015	0.00661	CcSEcCtD
Disopyramide—Blood creatinine increased—Cisplatin—germ cell cancer	0.0015	0.00661	CcSEcCtD
Disopyramide—CHRM3—telencephalon—germ cell cancer	0.0015	0.0147	CbGeAlD
Disopyramide—Hypoaesthesia—Bleomycin—germ cell cancer	0.0015	0.00659	CcSEcCtD
Disopyramide—Pollakiuria—Ifosfamide—germ cell cancer	0.00149	0.00653	CcSEcCtD
Disopyramide—Agranulocytosis—Dactinomycin—germ cell cancer	0.00146	0.00642	CcSEcCtD
Disopyramide—Hypokalaemia—Cisplatin—germ cell cancer	0.00146	0.00642	CcSEcCtD
Disopyramide—Ill-defined disorder—Vinblastine—germ cell cancer	0.00144	0.00633	CcSEcCtD
Disopyramide—Apnoea—Methotrexate—germ cell cancer	0.00143	0.00629	CcSEcCtD
Disopyramide—Hepatitis—Dactinomycin—germ cell cancer	0.0014	0.00618	CcSEcCtD
Disopyramide—Malaise—Vinblastine—germ cell cancer	0.0014	0.00615	CcSEcCtD
Disopyramide—Cardiac arrest—Etoposide—germ cell cancer	0.0014	0.00614	CcSEcCtD
Disopyramide—Vertigo—Vinblastine—germ cell cancer	0.00139	0.00613	CcSEcCtD
Disopyramide—ORM1—bone marrow—germ cell cancer	0.00139	0.0136	CbGeAlD
Disopyramide—ORM1—spinal cord—germ cell cancer	0.00139	0.0136	CbGeAlD
Disopyramide—KCND2—Circadian rythm related genes—AVP—germ cell cancer	0.00138	0.0103	CbGpPWpGaD
Disopyramide—Sweating increased—Cisplatin—germ cell cancer	0.00135	0.00594	CcSEcCtD
Disopyramide—SCN5A—head—germ cell cancer	0.00135	0.0132	CbGeAlD
Disopyramide—Agranulocytosis—Ifosfamide—germ cell cancer	0.00134	0.00588	CcSEcCtD
Disopyramide—Bradycardia—Ifosfamide—germ cell cancer	0.00131	0.00576	CcSEcCtD
Disopyramide—Discomfort—Vinblastine—germ cell cancer	0.00131	0.00574	CcSEcCtD
Disopyramide—Hepatitis—Ifosfamide—germ cell cancer	0.00129	0.00566	CcSEcCtD
Disopyramide—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00128	0.00564	CcSEcCtD
Disopyramide—ORM1—endocrine gland—germ cell cancer	0.00125	0.0122	CbGeAlD
Disopyramide—Thrombocytopenia—Vinblastine—germ cell cancer	0.00124	0.00545	CcSEcCtD
Disopyramide—Sweating increased—Etoposide—germ cell cancer	0.00124	0.00544	CcSEcCtD
Disopyramide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00123	0.0092	CbGpPWpGaD
Disopyramide—Ill-defined disorder—Bleomycin—germ cell cancer	0.00122	0.00535	CcSEcCtD
Disopyramide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00122	0.00906	CbGpPWpGaD
Disopyramide—Anorexia—Vinblastine—germ cell cancer	0.00121	0.00531	CcSEcCtD
Disopyramide—Neutropenia—Etoposide—germ cell cancer	0.00119	0.00522	CcSEcCtD
Disopyramide—Malaise—Bleomycin—germ cell cancer	0.00118	0.0052	CcSEcCtD
Disopyramide—CHRM2—endocrine gland—germ cell cancer	0.00116	0.0114	CbGeAlD
Disopyramide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00115	0.00858	CbGpPWpGaD
Disopyramide—Arrhythmia—Ifosfamide—germ cell cancer	0.00115	0.00506	CcSEcCtD
Disopyramide—CHRM2—head—germ cell cancer	0.00115	0.0113	CbGeAlD
Disopyramide—SLC22A1—endocrine gland—germ cell cancer	0.00114	0.0112	CbGeAlD
Disopyramide—Paraesthesia—Vinblastine—germ cell cancer	0.00114	0.005	CcSEcCtD
Disopyramide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00113	0.00499	CcSEcCtD
Disopyramide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00113	0.00845	CbGpPWpGaD
Disopyramide—Bradycardia—Cisplatin—germ cell cancer	0.00113	0.00497	CcSEcCtD
Disopyramide—SLC22A1—head—germ cell cancer	0.00113	0.0111	CbGeAlD
Disopyramide—Chest pain—Bleomycin—germ cell cancer	0.00112	0.00491	CcSEcCtD
Disopyramide—Coma—Methotrexate—germ cell cancer	0.00111	0.00487	CcSEcCtD
Disopyramide—Discomfort—Bleomycin—germ cell cancer	0.0011	0.00485	CcSEcCtD
Disopyramide—Malaise—Dactinomycin—germ cell cancer	0.0011	0.00485	CcSEcCtD
Disopyramide—Decreased appetite—Vinblastine—germ cell cancer	0.0011	0.00484	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00109	0.00814	CbGpPWpGaD
Disopyramide—Gynaecomastia—Methotrexate—germ cell cancer	0.00109	0.00477	CcSEcCtD
Disopyramide—Pain—Vinblastine—germ cell cancer	0.00108	0.00476	CcSEcCtD
Disopyramide—Constipation—Vinblastine—germ cell cancer	0.00108	0.00476	CcSEcCtD
Disopyramide—Confusional state—Bleomycin—germ cell cancer	0.00108	0.00474	CcSEcCtD
Disopyramide—Oedema—Bleomycin—germ cell cancer	0.00107	0.0047	CcSEcCtD
Disopyramide—SCN5A—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.00107	0.00794	CbGpPWpGaD
Disopyramide—CHRM1—endocrine gland—germ cell cancer	0.00106	0.0104	CbGeAlD
Disopyramide—Agranulocytosis—Etoposide—germ cell cancer	0.00106	0.00465	CcSEcCtD
Disopyramide—Vision blurred—Ifosfamide—germ cell cancer	0.00106	0.00464	CcSEcCtD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00106	0.00786	CbGpPWpGaD
Disopyramide—Thrombocytopenia—Bleomycin—germ cell cancer	0.00105	0.00461	CcSEcCtD
Disopyramide—CHRM1—head—germ cell cancer	0.00105	0.0102	CbGeAlD
Disopyramide—Feeling abnormal—Vinblastine—germ cell cancer	0.00104	0.00459	CcSEcCtD
Disopyramide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00104	0.00457	CcSEcCtD
Disopyramide—Discomfort—Dactinomycin—germ cell cancer	0.00103	0.00452	CcSEcCtD
Disopyramide—Angioedema—Ifosfamide—germ cell cancer	0.00102	0.0045	CcSEcCtD
Disopyramide—Anorexia—Bleomycin—germ cell cancer	0.00102	0.00448	CcSEcCtD
Disopyramide—CHRM3—female gonad—germ cell cancer	0.00102	0.00999	CbGeAlD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00102	0.00757	CbGpPWpGaD
Disopyramide—Hypoaesthesia—Etoposide—germ cell cancer	0.00101	0.00445	CcSEcCtD
Disopyramide—Malaise—Ifosfamide—germ cell cancer	0.00101	0.00444	CcSEcCtD
Disopyramide—Vertigo—Ifosfamide—germ cell cancer	0.00101	0.00443	CcSEcCtD
Disopyramide—Hypotension—Bleomycin—germ cell cancer	0.001	0.0044	CcSEcCtD
Disopyramide—Oedema—Dactinomycin—germ cell cancer	0.000998	0.00439	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—TDGF1—germ cell cancer	0.000998	0.00743	CbGpPWpGaD
Disopyramide—Arrhythmia—Cisplatin—germ cell cancer	0.000991	0.00436	CcSEcCtD
Disopyramide—SCN5A—brain—germ cell cancer	0.000978	0.00958	CbGeAlD
Disopyramide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000977	0.0043	CcSEcCtD
Disopyramide—Paraesthesia—Bleomycin—germ cell cancer	0.000961	0.00422	CcSEcCtD
Disopyramide—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000954	0.00711	CbGpPWpGaD
Disopyramide—Dyspnoea—Bleomycin—germ cell cancer	0.000954	0.00419	CcSEcCtD
Disopyramide—Chest pain—Ifosfamide—germ cell cancer	0.000954	0.00419	CcSEcCtD
Disopyramide—Flatulence—Cisplatin—germ cell cancer	0.000952	0.00419	CcSEcCtD
Disopyramide—Anorexia—Dactinomycin—germ cell cancer	0.000951	0.00418	CcSEcCtD
Disopyramide—CHRM3—endocrine gland—germ cell cancer	0.000948	0.00929	CbGeAlD
Disopyramide—Discomfort—Ifosfamide—germ cell cancer	0.000943	0.00414	CcSEcCtD
Disopyramide—CHRM3—head—germ cell cancer	0.000936	0.00917	CbGeAlD
Disopyramide—Decreased appetite—Bleomycin—germ cell cancer	0.00093	0.00409	CcSEcCtD
Disopyramide—Confusional state—Ifosfamide—germ cell cancer	0.000922	0.00405	CcSEcCtD
Disopyramide—Pain—Bleomycin—germ cell cancer	0.000915	0.00402	CcSEcCtD
Disopyramide—Oedema—Ifosfamide—germ cell cancer	0.000915	0.00402	CcSEcCtD
Disopyramide—Vision blurred—Cisplatin—germ cell cancer	0.00091	0.004	CcSEcCtD
Disopyramide—Asthenia—Vinblastine—germ cell cancer	0.000909	0.004	CcSEcCtD
Disopyramide—CHRM3—testis—germ cell cancer	0.000904	0.00886	CbGeAlD
Disopyramide—Ill-defined disorder—Cisplatin—germ cell cancer	0.000896	0.00394	CcSEcCtD
Disopyramide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000895	0.00394	CcSEcCtD
Disopyramide—Skin disorder—Ifosfamide—germ cell cancer	0.000888	0.00391	CcSEcCtD
Disopyramide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000884	0.00389	CcSEcCtD
Disopyramide—Feeling abnormal—Bleomycin—germ cell cancer	0.000882	0.00388	CcSEcCtD
Disopyramide—Anorexia—Ifosfamide—germ cell cancer	0.000872	0.00383	CcSEcCtD
Disopyramide—Malaise—Cisplatin—germ cell cancer	0.000871	0.00383	CcSEcCtD
Disopyramide—Decreased appetite—Dactinomycin—germ cell cancer	0.000868	0.00381	CcSEcCtD
Disopyramide—Diarrhoea—Vinblastine—germ cell cancer	0.000867	0.00381	CcSEcCtD
Disopyramide—Dysgeusia—Etoposide—germ cell cancer	0.000867	0.00381	CcSEcCtD
Disopyramide—ORM1—lymph node—germ cell cancer	0.000863	0.00845	CbGeAlD
Disopyramide—Fatigue—Dactinomycin—germ cell cancer	0.00086	0.00378	CcSEcCtD
Disopyramide—Hypotension—Ifosfamide—germ cell cancer	0.000855	0.00376	CcSEcCtD
Disopyramide—Pain—Dactinomycin—germ cell cancer	0.000853	0.00375	CcSEcCtD
Disopyramide—Urticaria—Bleomycin—germ cell cancer	0.00085	0.00374	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—SALL4—germ cell cancer	0.000849	0.00632	CbGpPWpGaD
Disopyramide—Body temperature increased—Bleomycin—germ cell cancer	0.000846	0.00372	CcSEcCtD
Disopyramide—Dizziness—Vinblastine—germ cell cancer	0.000838	0.00368	CcSEcCtD
Disopyramide—CHRM2—brain—germ cell cancer	0.000833	0.00816	CbGeAlD
Disopyramide—Feeling abnormal—Dactinomycin—germ cell cancer	0.000822	0.00362	CcSEcCtD
Disopyramide—Paraesthesia—Ifosfamide—germ cell cancer	0.000821	0.00361	CcSEcCtD
Disopyramide—Ill-defined disorder—Etoposide—germ cell cancer	0.000821	0.00361	CcSEcCtD
Disopyramide—SLC22A1—brain—germ cell cancer	0.000818	0.00801	CbGeAlD
Disopyramide—Dyspnoea—Ifosfamide—germ cell cancer	0.000815	0.00358	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—NANOG—germ cell cancer	0.000813	0.00606	CbGpPWpGaD
Disopyramide—Somnolence—Ifosfamide—germ cell cancer	0.000813	0.00357	CcSEcCtD
Disopyramide—Discomfort—Cisplatin—germ cell cancer	0.000813	0.00357	CcSEcCtD
Disopyramide—Vomiting—Vinblastine—germ cell cancer	0.000806	0.00354	CcSEcCtD
Disopyramide—Malaise—Etoposide—germ cell cancer	0.000798	0.00351	CcSEcCtD
Disopyramide—Vertigo—Etoposide—germ cell cancer	0.000795	0.0035	CcSEcCtD
Disopyramide—Decreased appetite—Ifosfamide—germ cell cancer	0.000795	0.0035	CcSEcCtD
Disopyramide—Headache—Vinblastine—germ cell cancer	0.000794	0.00349	CcSEcCtD
Disopyramide—Body temperature increased—Dactinomycin—germ cell cancer	0.000789	0.00347	CcSEcCtD
Disopyramide—Fatigue—Ifosfamide—germ cell cancer	0.000789	0.00347	CcSEcCtD
Disopyramide—Oedema—Cisplatin—germ cell cancer	0.000788	0.00347	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—POU5F1—germ cell cancer	0.000783	0.00583	CbGpPWpGaD
Disopyramide—Pain—Ifosfamide—germ cell cancer	0.000782	0.00344	CcSEcCtD
Disopyramide—Constipation—Ifosfamide—germ cell cancer	0.000782	0.00344	CcSEcCtD
Disopyramide—Loss of consciousness—Etoposide—germ cell cancer	0.000778	0.00342	CcSEcCtD
Disopyramide—Thrombocytopenia—Cisplatin—germ cell cancer	0.000772	0.00339	CcSEcCtD
Disopyramide—Asthenia—Bleomycin—germ cell cancer	0.000768	0.00338	CcSEcCtD
Disopyramide—Skin disorder—Cisplatin—germ cell cancer	0.000766	0.00337	CcSEcCtD
Disopyramide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000762	0.00335	CcSEcCtD
Disopyramide—CHRM1—brain—germ cell cancer	0.000758	0.00743	CbGeAlD
Disopyramide—Pruritus—Bleomycin—germ cell cancer	0.000757	0.00333	CcSEcCtD
Disopyramide—Feeling abnormal—Ifosfamide—germ cell cancer	0.000754	0.00331	CcSEcCtD
Disopyramide—Chest pain—Etoposide—germ cell cancer	0.000754	0.00331	CcSEcCtD
Disopyramide—Nausea—Vinblastine—germ cell cancer	0.000753	0.00331	CcSEcCtD
Disopyramide—Anorexia—Cisplatin—germ cell cancer	0.000752	0.0033	CcSEcCtD
Disopyramide—Discomfort—Etoposide—germ cell cancer	0.000744	0.00327	CcSEcCtD
Disopyramide—Hypotension—Cisplatin—germ cell cancer	0.000737	0.00324	CcSEcCtD
Disopyramide—Confusional state—Etoposide—germ cell cancer	0.000728	0.0032	CcSEcCtD
Disopyramide—Urticaria—Ifosfamide—germ cell cancer	0.000727	0.00319	CcSEcCtD
Disopyramide—Body temperature increased—Ifosfamide—germ cell cancer	0.000723	0.00318	CcSEcCtD
Disopyramide—Asthenia—Dactinomycin—germ cell cancer	0.000716	0.00315	CcSEcCtD
Disopyramide—Dysuria—Methotrexate—germ cell cancer	0.000711	0.00313	CcSEcCtD
Disopyramide—Neutropenia—Methotrexate—germ cell cancer	0.000711	0.00313	CcSEcCtD
Disopyramide—Paraesthesia—Cisplatin—germ cell cancer	0.000708	0.00311	CcSEcCtD
Disopyramide—Thrombocytopenia—Etoposide—germ cell cancer	0.000707	0.00311	CcSEcCtD
Disopyramide—Dyspnoea—Cisplatin—germ cell cancer	0.000703	0.00309	CcSEcCtD
Disopyramide—Skin disorder—Etoposide—germ cell cancer	0.000702	0.00308	CcSEcCtD
Disopyramide—Erectile dysfunction—Methotrexate—germ cell cancer	0.000701	0.00308	CcSEcCtD
Disopyramide—Hyperhidrosis—Etoposide—germ cell cancer	0.000698	0.00307	CcSEcCtD
Disopyramide—Anorexia—Etoposide—germ cell cancer	0.000689	0.00303	CcSEcCtD
Disopyramide—Decreased appetite—Cisplatin—germ cell cancer	0.000685	0.00301	CcSEcCtD
Disopyramide—Diarrhoea—Dactinomycin—germ cell cancer	0.000683	0.003	CcSEcCtD
Disopyramide—Vomiting—Bleomycin—germ cell cancer	0.00068	0.00299	CcSEcCtD
Disopyramide—Drowsiness—Methotrexate—germ cell cancer	0.000678	0.00298	CcSEcCtD
Disopyramide—CHRM3—brain—germ cell cancer	0.000678	0.00665	CbGeAlD
Disopyramide—Depression—Methotrexate—germ cell cancer	0.000676	0.00297	CcSEcCtD
Disopyramide—Hypotension—Etoposide—germ cell cancer	0.000675	0.00297	CcSEcCtD
Disopyramide—Rash—Bleomycin—germ cell cancer	0.000675	0.00297	CcSEcCtD
Disopyramide—Pain—Cisplatin—germ cell cancer	0.000674	0.00296	CcSEcCtD
Disopyramide—Dermatitis—Bleomycin—germ cell cancer	0.000674	0.00296	CcSEcCtD
Disopyramide—Asthenia—Ifosfamide—germ cell cancer	0.000656	0.00288	CcSEcCtD
Disopyramide—Feeling abnormal—Cisplatin—germ cell cancer	0.00065	0.00286	CcSEcCtD
Disopyramide—Paraesthesia—Etoposide—germ cell cancer	0.000649	0.00285	CcSEcCtD
Disopyramide—Pruritus—Ifosfamide—germ cell cancer	0.000647	0.00284	CcSEcCtD
Disopyramide—Dyspnoea—Etoposide—germ cell cancer	0.000644	0.00283	CcSEcCtD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000644	0.0048	CbGpPWpGaD
Disopyramide—Somnolence—Etoposide—germ cell cancer	0.000642	0.00282	CcSEcCtD
Disopyramide—Nausea—Bleomycin—germ cell cancer	0.000636	0.00279	CcSEcCtD
Disopyramide—Vomiting—Dactinomycin—germ cell cancer	0.000635	0.00279	CcSEcCtD
Disopyramide—Agranulocytosis—Methotrexate—germ cell cancer	0.000633	0.00278	CcSEcCtD
Disopyramide—Rash—Dactinomycin—germ cell cancer	0.000629	0.00277	CcSEcCtD
Disopyramide—Decreased appetite—Etoposide—germ cell cancer	0.000628	0.00276	CcSEcCtD
Disopyramide—Diarrhoea—Ifosfamide—germ cell cancer	0.000626	0.00275	CcSEcCtD
Disopyramide—Body temperature increased—Cisplatin—germ cell cancer	0.000623	0.00274	CcSEcCtD
Disopyramide—Fatigue—Etoposide—germ cell cancer	0.000623	0.00274	CcSEcCtD
Disopyramide—Pain—Etoposide—germ cell cancer	0.000618	0.00272	CcSEcCtD
Disopyramide—Constipation—Etoposide—germ cell cancer	0.000618	0.00272	CcSEcCtD
Disopyramide—SCN5A—Developmental Biology—KLF4—germ cell cancer	0.000617	0.00459	CbGpPWpGaD
Disopyramide—Hepatitis—Methotrexate—germ cell cancer	0.000609	0.00268	CcSEcCtD
Disopyramide—Dizziness—Ifosfamide—germ cell cancer	0.000605	0.00266	CcSEcCtD
Disopyramide—Feeling abnormal—Etoposide—germ cell cancer	0.000595	0.00262	CcSEcCtD
Disopyramide—Nausea—Dactinomycin—germ cell cancer	0.000593	0.00261	CcSEcCtD
Disopyramide—Vomiting—Ifosfamide—germ cell cancer	0.000582	0.00256	CcSEcCtD
Disopyramide—Rash—Ifosfamide—germ cell cancer	0.000577	0.00254	CcSEcCtD
Disopyramide—Dermatitis—Ifosfamide—germ cell cancer	0.000576	0.00253	CcSEcCtD
Disopyramide—Urticaria—Etoposide—germ cell cancer	0.000574	0.00252	CcSEcCtD
Disopyramide—Body temperature increased—Etoposide—germ cell cancer	0.000571	0.00251	CcSEcCtD
Disopyramide—Asthenia—Cisplatin—germ cell cancer	0.000566	0.00249	CcSEcCtD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000563	0.0042	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000561	0.00418	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000553	0.00412	CbGpPWpGaD
Disopyramide—Nausea—Ifosfamide—germ cell cancer	0.000543	0.00239	CcSEcCtD
Disopyramide—Diarrhoea—Cisplatin—germ cell cancer	0.000539	0.00237	CcSEcCtD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000523	0.0039	CbGpPWpGaD
Disopyramide—CYP3A4—endocrine gland—germ cell cancer	0.000521	0.0051	CbGeAlD
Disopyramide—Dysgeusia—Methotrexate—germ cell cancer	0.000519	0.00228	CcSEcCtD
Disopyramide—Asthenia—Etoposide—germ cell cancer	0.000518	0.00228	CcSEcCtD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000515	0.00384	CbGpPWpGaD
Disopyramide—Pruritus—Etoposide—germ cell cancer	0.000511	0.00225	CcSEcCtD
Disopyramide—Vomiting—Cisplatin—germ cell cancer	0.000501	0.0022	CcSEcCtD
Disopyramide—Vision blurred—Methotrexate—germ cell cancer	0.0005	0.0022	CcSEcCtD
Disopyramide—Rash—Cisplatin—germ cell cancer	0.000497	0.00219	CcSEcCtD
Disopyramide—Dermatitis—Cisplatin—germ cell cancer	0.000497	0.00218	CcSEcCtD
Disopyramide—Diarrhoea—Etoposide—germ cell cancer	0.000494	0.00217	CcSEcCtD
Disopyramide—Ill-defined disorder—Methotrexate—germ cell cancer	0.000492	0.00216	CcSEcCtD
Disopyramide—Malaise—Methotrexate—germ cell cancer	0.000478	0.0021	CcSEcCtD
Disopyramide—Dizziness—Etoposide—germ cell cancer	0.000478	0.0021	CcSEcCtD
Disopyramide—Vertigo—Methotrexate—germ cell cancer	0.000476	0.00209	CcSEcCtD
Disopyramide—Nausea—Cisplatin—germ cell cancer	0.000468	0.00206	CcSEcCtD
Disopyramide—Vomiting—Etoposide—germ cell cancer	0.000459	0.00202	CcSEcCtD
Disopyramide—Rash—Etoposide—germ cell cancer	0.000455	0.002	CcSEcCtD
Disopyramide—Dermatitis—Etoposide—germ cell cancer	0.000455	0.002	CcSEcCtD
Disopyramide—Headache—Etoposide—germ cell cancer	0.000453	0.00199	CcSEcCtD
Disopyramide—Chest pain—Methotrexate—germ cell cancer	0.000451	0.00198	CcSEcCtD
Disopyramide—Discomfort—Methotrexate—germ cell cancer	0.000446	0.00196	CcSEcCtD
Disopyramide—Confusional state—Methotrexate—germ cell cancer	0.000436	0.00192	CcSEcCtD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000436	0.00325	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000435	0.00324	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—SOX2—germ cell cancer	0.000434	0.00324	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—TP53—germ cell cancer	0.000434	0.00324	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000433	0.00323	CbGpPWpGaD
Disopyramide—Nausea—Etoposide—germ cell cancer	0.000429	0.00189	CcSEcCtD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000429	0.0032	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—OXT—germ cell cancer	0.000425	0.00316	CbGpPWpGaD
Disopyramide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000424	0.00186	CcSEcCtD
Disopyramide—CHRM3—G alpha (q) signalling events—OXT—germ cell cancer	0.000423	0.00315	CbGpPWpGaD
Disopyramide—Skin disorder—Methotrexate—germ cell cancer	0.00042	0.00185	CcSEcCtD
Disopyramide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000418	0.00184	CcSEcCtD
Disopyramide—Anorexia—Methotrexate—germ cell cancer	0.000412	0.00181	CcSEcCtD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000406	0.00303	CbGpPWpGaD
Disopyramide—Hypotension—Methotrexate—germ cell cancer	0.000404	0.00178	CcSEcCtD
Disopyramide—Insomnia—Methotrexate—germ cell cancer	0.000391	0.00172	CcSEcCtD
Disopyramide—Paraesthesia—Methotrexate—germ cell cancer	0.000389	0.00171	CcSEcCtD
Disopyramide—Dyspnoea—Methotrexate—germ cell cancer	0.000386	0.0017	CcSEcCtD
Disopyramide—Somnolence—Methotrexate—germ cell cancer	0.000385	0.00169	CcSEcCtD
Disopyramide—Dyspepsia—Methotrexate—germ cell cancer	0.000381	0.00167	CcSEcCtD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00038	0.00283	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000378	0.00282	CbGpPWpGaD
Disopyramide—Decreased appetite—Methotrexate—germ cell cancer	0.000376	0.00165	CcSEcCtD
Disopyramide—Fatigue—Methotrexate—germ cell cancer	0.000373	0.00164	CcSEcCtD
Disopyramide—Pain—Methotrexate—germ cell cancer	0.00037	0.00163	CcSEcCtD
Disopyramide—KCND3—Neuronal System—HRAS—germ cell cancer	0.000358	0.00267	CbGpPWpGaD
Disopyramide—Feeling abnormal—Methotrexate—germ cell cancer	0.000357	0.00157	CcSEcCtD
Disopyramide—Urticaria—Methotrexate—germ cell cancer	0.000344	0.00151	CcSEcCtD
Disopyramide—Body temperature increased—Methotrexate—germ cell cancer	0.000342	0.0015	CcSEcCtD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000332	0.00247	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—HRAS—germ cell cancer	0.000319	0.00238	CbGpPWpGaD
Disopyramide—Asthenia—Methotrexate—germ cell cancer	0.00031	0.00136	CcSEcCtD
Disopyramide—Pruritus—Methotrexate—germ cell cancer	0.000306	0.00135	CcSEcCtD
Disopyramide—Diarrhoea—Methotrexate—germ cell cancer	0.000296	0.0013	CcSEcCtD
Disopyramide—CHRM1—G alpha (q) signalling events—AVP—germ cell cancer	0.000291	0.00217	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—AVP—germ cell cancer	0.00029	0.00216	CbGpPWpGaD
Disopyramide—Dizziness—Methotrexate—germ cell cancer	0.000286	0.00126	CcSEcCtD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000285	0.00212	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000281	0.00209	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000281	0.00209	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00028	0.00209	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000278	0.00207	CbGpPWpGaD
Disopyramide—Vomiting—Methotrexate—germ cell cancer	0.000275	0.00121	CcSEcCtD
Disopyramide—CHRM1—Circadian rythm related genes—AVP—germ cell cancer	0.000275	0.00205	CbGpPWpGaD
Disopyramide—Rash—Methotrexate—germ cell cancer	0.000273	0.0012	CcSEcCtD
Disopyramide—Dermatitis—Methotrexate—germ cell cancer	0.000273	0.0012	CcSEcCtD
Disopyramide—Headache—Methotrexate—germ cell cancer	0.000271	0.00119	CcSEcCtD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000266	0.00198	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000265	0.00198	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000264	0.00197	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000262	0.00195	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000262	0.00195	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.00026	0.00194	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000259	0.00193	CbGpPWpGaD
Disopyramide—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000259	0.00193	CbGpPWpGaD
Disopyramide—Nausea—Methotrexate—germ cell cancer	0.000257	0.00113	CcSEcCtD
Disopyramide—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000241	0.0018	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—OXT—germ cell cancer	0.000214	0.0016	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—OXT—germ cell cancer	0.000213	0.00159	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—OXT—germ cell cancer	0.000211	0.00157	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000193	0.00144	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000192	0.00143	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00019	0.00142	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—AVP—germ cell cancer	0.000147	0.00109	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—AVP—germ cell cancer	0.000146	0.00109	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—AVP—germ cell cancer	0.000145	0.00108	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC2A3—germ cell cancer	0.000134	0.000995	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—SLC22A3—germ cell cancer	0.000132	0.00098	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000132	0.00098	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC2A3—germ cell cancer	0.000124	0.000927	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—SLC22A3—germ cell cancer	0.000123	0.000914	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000123	0.000913	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—OXT—germ cell cancer	0.000121	0.000901	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—OXT—germ cell cancer	0.000121	0.000899	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—OXT—germ cell cancer	0.000119	0.00089	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC2A3—germ cell cancer	0.000115	0.000857	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—SLC22A3—germ cell cancer	0.000113	0.000844	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—OXT—germ cell cancer	0.00011	0.000819	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—OXT—germ cell cancer	0.00011	0.000816	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—OXT—germ cell cancer	0.000108	0.000808	CbGpPWpGaD
Disopyramide—SCN5A—Axon guidance—HRAS—germ cell cancer	0.000108	0.000806	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CRABP1—germ cell cancer	0.000107	0.000799	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CRABP1—germ cell cancer	0.0001	0.000745	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	9.63e-05	0.000718	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CRABP1—germ cell cancer	9.23e-05	0.000688	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	8.98e-05	0.000669	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—TP53—germ cell cancer	8.66e-05	0.000646	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AVP—germ cell cancer	8.29e-05	0.000618	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AVP—germ cell cancer	8.27e-05	0.000616	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AVP—germ cell cancer	8.19e-05	0.00061	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	7.85e-05	0.000585	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	7.83e-05	0.000583	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—HRAS—germ cell cancer	7.72e-05	0.000575	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AVP—germ cell cancer	7.53e-05	0.000561	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AVP—germ cell cancer	7.51e-05	0.000559	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AVP—germ cell cancer	7.43e-05	0.000554	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—HRAS—germ cell cancer	7.38e-05	0.00055	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—HRAS—germ cell cancer	6.88e-05	0.000512	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—OXT—germ cell cancer	6.49e-05	0.000484	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—OXT—germ cell cancer	6.47e-05	0.000482	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—OXT—germ cell cancer	6.41e-05	0.000477	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGF4—germ cell cancer	5.54e-05	0.000413	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGF4—germ cell cancer	5.52e-05	0.000411	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGF4—germ cell cancer	5.47e-05	0.000407	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—H2AFZ—germ cell cancer	4.95e-05	0.000369	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—H2AFZ—germ cell cancer	4.93e-05	0.000367	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	4.88e-05	0.000364	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KITLG—germ cell cancer	4.55e-05	0.000339	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KITLG—germ cell cancer	4.54e-05	0.000338	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A3—germ cell cancer	4.5e-05	0.000335	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KITLG—germ cell cancer	4.49e-05	0.000335	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AVP—germ cell cancer	4.45e-05	0.000331	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AVP—germ cell cancer	4.43e-05	0.00033	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC22A3—germ cell cancer	4.43e-05	0.00033	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AVP—germ cell cancer	4.39e-05	0.000327	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.61e-05	0.000269	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGFR3—germ cell cancer	3.38e-05	0.000252	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGFR3—germ cell cancer	3.37e-05	0.000251	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	3.34e-05	0.000249	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KIT—germ cell cancer	3.11e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KIT—germ cell cancer	3.1e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KIT—germ cell cancer	3.07e-05	0.000228	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HRAS—germ cell cancer	2.27e-05	0.000169	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HRAS—germ cell cancer	2.26e-05	0.000169	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	2.24e-05	0.000167	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—germ cell cancer	1.71e-05	0.000127	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—germ cell cancer	1.7e-05	0.000127	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—germ cell cancer	1.69e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—germ cell cancer	1.4e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—germ cell cancer	1.4e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—germ cell cancer	1.39e-05	0.000103	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HRAS—germ cell cancer	1.34e-05	0.0001	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HRAS—germ cell cancer	1.34e-05	9.97e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HRAS—germ cell cancer	1.32e-05	9.87e-05	CbGpPWpGaD
